Home › Funds › ESSEX INVESTMENT MANAGEMENT CO LLC › KNSA
ESSEX INVESTMENT MANAGEMENT CO LLC position in KNSA
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A · Health Care
ESSEX INVESTMENT MANAGEMENT CO LLC reported holding 202,021 shares of KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A) in its Q3 2026 13F filing — a position valued at US$15.1M, representing 2.24% of its reported portfolio and ranking #2 among its reported holdings. ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How ESSEX INVESTMENT MANAGEMENT CO LLC's KNSA position evolved
ESSEX INVESTMENT MANAGEMENT CO LLC first disclosed a stake in KNSA in Q3 2023 at 185,853 shares (US$3.2M). The position peaked in Q2 2026 at 241,382 shares, worth US$15.4M. Across 13 filings, ESSEX INVESTMENT MANAGEMENT CO LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 202,021 shares valued at US$15.1M — a reduction of -39,361 shares quarter over quarter.. Notable position changes include a 44% increase in Q3 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 185.85K | $3.23M | New |
| Q4 2023 | 171.89K | $3.01M | Reduce |
| Q1 2024 | 172.74K | $3.41M | Hold |
| Q2 2024 | 199.80K | $3.73M | Add |
| Q3 2024 | 200.52K | $5.01M | Hold |
| Q4 2024 | 173.80K | $3.44M | Reduce |
| Q1 2025 | 172.67K | $3.83M | Reduce |
| Q2 2025 | 171.44K | $4.74M | Reduce |
| Q3 2025 | 247.30K | $9.60M | Add |
| Q4 2025 | 250.97K | $10.35M | Add |
| Q1 2026 | 249.28K | $12.00M | Reduce |
| Q2 2026 | 241.38K | $15.44M | Reduce |
| Q3 2026 | 202.02K | $15.07M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KNSA and 13F data
KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A) is a Health Care company. 48 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KNSA
- Rubric Capital Management LP 4.00M sh · $255.79M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M sh · $181.28M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.26M sh · $144.52M · Q2 2026
- Spruce Street Capital LP 918.07K sh · $58.71M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 624.93K sh · $39.96M · Q2 2026
- ORBIMED ADVISORS LLC 420.60K sh · $26.90M · Q2 2026
- Penn Capital Management Company, LLC 368.11K sh · $23.57M · Q2 2026
- Soleus Capital Management, L.P. 246.35K sh · $15.75M · Q2 2026
- ArrowMark Colorado Holdings LLC 215.55K sh · $13.78M · Q2 2026
- STEMPOINT CAPITAL LP 209.23K sh · $13.38M · Q2 2026
More on ESSEX INVESTMENT MANAGEMENT CO LLC
FAQ
How long has ESSEX INVESTMENT MANAGEMENT CO LLC held KNSA?
ESSEX INVESTMENT MANAGEMENT CO LLC has disclosed KNSA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ESSEX INVESTMENT MANAGEMENT CO LLC's current position in KNSA?
As of Q3 2026, ESSEX INVESTMENT MANAGEMENT CO LLC holds 202.02K shares of KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A), valued at $15.07M, representing 2.24% of its reported portfolio and ranking #2.
Has ESSEX INVESTMENT MANAGEMENT CO LLC been buying or selling KNSA?
In the latest 13F filing (Q3 2026), ESSEX INVESTMENT MANAGEMENT CO LLC reduced its position in KNSA. The position peaked in Q2 2026 at 241.38K shares.
Which other funds hold KNSA?
Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.